Orkla Foods Danmark has entered into an agreement with Stryhns A/S to sell its K-Salat line as it aims to concentrate on fewer categories.
The agreement concerns the 100% divestment of K-Salat, which has a product portfolio of salad spreads, mayonnaise, remoulade, dressings and potato salads in Denmark.
As part of the deal, Danish company Stryhns A/S will take over the K-Salat factory in Havnsø, Vestsjælland, which has 100 employees.
K-Salat was founded in 1937 under the name Københavns Salatfabrik. The business was later moved to Havnsø, and its name was changed to K-Salat.
CEO of Orkla Foods Danmark Tino Bendix said: “We are glad to be able to sell K-Salat to Stryhns, which has the strong competence necessary to further develop the business.
“From now on, Orkla Foods Danmark will concentrate its core assortment on the well-known brands Beauvais, Den Gamle Fabrik, Glyngøre, Bähncke, Fun, Grønnegården and Risifrutti.”
The transaction is expected to be completed in early December 2017, and the entity will be consolidated into the buyer’s financial statements from 1 December 2017.
Last month Orkla expanded in the ingredients segment with the acquisition of Norwegian company Arne B. Corneliussen from Danish Crown.
In March, it acquired the Dutch ice cream ingredients and accessories company Laan Heiloo for an undisclosed sum.
A report from ingredients supplier Henley Bridge has warned that cocoa price increases of 15-20% for the first half of 2024 might continue into the second half of the year. Despite growth in global cocoa supply in 2021, unfavourable weather conditions and demand from emerging markets have led to supply deficits.
By carving out the ANH business, DSM-Firmenich would focus fully on its Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care divisions. Full focus on these businesses is expected to enhance commercial potential and synergies, supporting “consistent growth outlook alongside robust margins”.
Cargill and Enough are expanding their partnership to further develop nutritious and sustainable alternative meat and dairy solutions. Cargill has signed a commercial agreement to use and market Enough’s Abunda protein and has also invested in the company’s Series C growth funding round.